content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

bluebird Bio (BLUE)

126.90
2.10
(1.68%)
Sep 11, 4:00PM EDT
content_middle

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer in Cambridge, Massachusetts and Seattle, Washington.

BLUE’s product candidates include Lenti-D that is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare hereditary neurological disorder; and LentiGlobin, which is in four clinical studies for the treatment of transfusion-dependent ß-thalassemia, and severe sickle cell disease. The company's lead product candidate in oncology is bb2121, a chimeric antigen receptor T cell product candidate that is in a Phase I trial for the treatment of relapsed/refractory multiple myeloma.

BLUE has a strategic collaborations with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology; and Kite Pharma (now Gilead). to develop and commercialize second generation T cell receptor (TCR) product candidates against an antigen related to certain cancers associated with the human papilloma virus. It also has strategic collaborations with Medigene AG for the research and development of TCR product candidates directed against approximately four antigens for the treatment of cancer indications; and TC BioPharm to research and develop gamma delta CAR T cell product candidates for cancer immunotherapy.

BLUE was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.

Previous Close: 
124.80
Open: 
125.55
Bid: 
126.65
Ask: 
127.00
1yr Target Price: 
116.47
Day's Range: 
124.80 - 128.30
52wk Range: 
37.05 - 133.10
Volume: 
729138
Average Daily Volume: 
966749
Market Capitalization: 
5.79B
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
45589000M
content_right

Pages